The Recall Desk
SevereFDA (Drugs)·D-1525-2019·Announced 2019-07-31

Geritrex Recalls Ritussin DM Due to Potential Microbial Contamination

Geritrex, LLC is recalling Ritussin DM Double Strength cough syrup due to cGMP deviations that may result in microbial contamination.

What this means for you

Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.

Our severity reasoning: The recall is classified as FDA Class II and involves potential microbial contamination, which meets the rubric criteria for a Severe rating due to the risk of significant injury.

Plain-English summary

Geritrex, LLC is voluntarily recalling 7,653 bottles of Ritussin DM Double Strength, 4 FL. OZ. (118 mL), manufactured by RIJ Pharmaceutical Corporation. The recall is being conducted because of Current Good Manufacturing Practice (cGMP) deviations that may have resulted in microbial contamination of the product.

The affected product is identified by Lot # 70611 and an expiration date of 6/19. The recall covers distribution nationwide in the United States.

Consumers who have this product should stop using it and contact Geritrex, LLC for further instructions or a refund.

The recalled product

Product
Ritussin DM Double Strength, 4 FL. OZ. (118 mL), RIJ Pharmaceutical Corporation 40 Commercial Avenue Middletown, NY 10941
Manufacturer
Geritrex, LLC
Affected units
7,653

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (2)

  • Lot #: 70611
  • Exp 6/19

Distribution

Distributed nationwide across the United States.

Part of a larger recall action

This product is one of 8 recalled by Geritrex, LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 8 products in this recall →